Applies to ergocalciferol: oral capsules and solution
Side effects include:
Possible hypervitaminosis D effects: polyuria,   nocturia,   polydipsia,   hypercalciuria,   reversible azotemia,   hypertension,   nephrocalcinosis,   generalized vascular calcification,   irreversible renal insufficiency (may be fatal),   mental retardation,   widespread soft tissue calcification,   osteoporosis,   dwarfism,   vague aches,   stiffness,   weakness,   nausea,   anorexia,   constipation,   mild acidosis,   anemia,   weight loss.  
Applies to ergocalciferol: compounding powder, injectable solution, oral capsule, oral solution, oral tablet
Rare (less than 0.1%): HypercalcemiaFrequency not reported: Hypervitaminosis D[Ref]
Hypervitaminosis D is characterized by: impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death; mental retardation; widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs; bone demineralization (osteoporosis) in adults; decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism), vague aches, stiffness, and weakness; nausea, anorexia, constipation; and mild acidosis, anemia, and weight loss.[Ref]
Rare (less than 0.1%): Hypercalciuria[Ref]
Rare (less than 0.1%): Pruritus, rash, urticaria[Ref]
1. "Product Information. Drisdol (ergocalciferol)." sanofi-aventis, Bridgewater, NJ. 
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
Not all side effects for ergocalciferol may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
